Influence of nitrovasodilators and cyclooxygenase inhibitors on cerebral vasoreactivity in conscious rabbits

Klára Csete, P. Barzó, Mihály Bodosi, J. Papp

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Since the nitric oxide (NO) and cyclooxygenase pathways have been suggested to have important roles in most vasodilations, our aim was to study the influence of cyclooxygenase inhibitors and nitrovasodilators on cerebrovascular reserve capacity. Corticocerebral blood flow was measured by hydrogen polarography during hypercapnia and acetazolamide stimuli in conscious rabbits. The measurements were repeated in the presence of Nω-nitro-L-arginine methyl ester (L-NAME) and indomethacin as nitric oxide synthase (NOS) and cyclooxygenase inhibitors. The effects of nitroglycerin and isosorbide-5-nitrate were also tested. L-NAME completely, while indomethacin markedly inhibited the hypercapnic corticocerebral blood flow response. Nitroglycerin and isosorbide-5-nitrate significantly attenuated hypercapnia elicited corticocerebral blood flow increase. The different treatments reduced only moderately the acetazolamide-induced corticocerebral blood flow response. These results lend support to the hypothesis that antithrombotic and antiinflammatory medication (cyclooxygenase inhibitors) and nitrovasodilator treatments could interfere with the measurement of cerebrovascular reactivity resulting in underestimation of the cerebrovascular reserve capacity in patients taking these drugs.

Original languageEnglish
Pages (from-to)301-309
Number of pages9
JournalEuropean Journal of Pharmacology
Volume412
Issue number3
DOIs
Publication statusPublished - Feb 2 2001

Fingerprint

Cyclooxygenase Inhibitors
isosorbide-5-mononitrate
Cerebral Cortex
Rabbits
Acetazolamide
Hypercapnia
NG-Nitroarginine Methyl Ester
Nitroglycerin
Indomethacin
Polarography
Prostaglandin-Endoperoxide Synthases
Vasodilation
Nitric Oxide Synthase
Hydrogen
Nitric Oxide
Anti-Inflammatory Agents
Therapeutics
Pharmaceutical Preparations

Keywords

  • Acetazolamide
  • Carbon dioxide
  • Cerebral vasoreactivity
  • Cyclooxygenase inhibitor
  • Nitrovasodilator

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Influence of nitrovasodilators and cyclooxygenase inhibitors on cerebral vasoreactivity in conscious rabbits. / Csete, Klára; Barzó, P.; Bodosi, Mihály; Papp, J.

In: European Journal of Pharmacology, Vol. 412, No. 3, 02.02.2001, p. 301-309.

Research output: Contribution to journalArticle

@article{86efd825bf384252afdfa693d214f3c3,
title = "Influence of nitrovasodilators and cyclooxygenase inhibitors on cerebral vasoreactivity in conscious rabbits",
abstract = "Since the nitric oxide (NO) and cyclooxygenase pathways have been suggested to have important roles in most vasodilations, our aim was to study the influence of cyclooxygenase inhibitors and nitrovasodilators on cerebrovascular reserve capacity. Corticocerebral blood flow was measured by hydrogen polarography during hypercapnia and acetazolamide stimuli in conscious rabbits. The measurements were repeated in the presence of Nω-nitro-L-arginine methyl ester (L-NAME) and indomethacin as nitric oxide synthase (NOS) and cyclooxygenase inhibitors. The effects of nitroglycerin and isosorbide-5-nitrate were also tested. L-NAME completely, while indomethacin markedly inhibited the hypercapnic corticocerebral blood flow response. Nitroglycerin and isosorbide-5-nitrate significantly attenuated hypercapnia elicited corticocerebral blood flow increase. The different treatments reduced only moderately the acetazolamide-induced corticocerebral blood flow response. These results lend support to the hypothesis that antithrombotic and antiinflammatory medication (cyclooxygenase inhibitors) and nitrovasodilator treatments could interfere with the measurement of cerebrovascular reactivity resulting in underestimation of the cerebrovascular reserve capacity in patients taking these drugs.",
keywords = "Acetazolamide, Carbon dioxide, Cerebral vasoreactivity, Cyclooxygenase inhibitor, Nitrovasodilator",
author = "Kl{\'a}ra Csete and P. Barz{\'o} and Mih{\'a}ly Bodosi and J. Papp",
year = "2001",
month = "2",
day = "2",
doi = "10.1016/S0014-2999(01)00725-7",
language = "English",
volume = "412",
pages = "301--309",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Influence of nitrovasodilators and cyclooxygenase inhibitors on cerebral vasoreactivity in conscious rabbits

AU - Csete, Klára

AU - Barzó, P.

AU - Bodosi, Mihály

AU - Papp, J.

PY - 2001/2/2

Y1 - 2001/2/2

N2 - Since the nitric oxide (NO) and cyclooxygenase pathways have been suggested to have important roles in most vasodilations, our aim was to study the influence of cyclooxygenase inhibitors and nitrovasodilators on cerebrovascular reserve capacity. Corticocerebral blood flow was measured by hydrogen polarography during hypercapnia and acetazolamide stimuli in conscious rabbits. The measurements were repeated in the presence of Nω-nitro-L-arginine methyl ester (L-NAME) and indomethacin as nitric oxide synthase (NOS) and cyclooxygenase inhibitors. The effects of nitroglycerin and isosorbide-5-nitrate were also tested. L-NAME completely, while indomethacin markedly inhibited the hypercapnic corticocerebral blood flow response. Nitroglycerin and isosorbide-5-nitrate significantly attenuated hypercapnia elicited corticocerebral blood flow increase. The different treatments reduced only moderately the acetazolamide-induced corticocerebral blood flow response. These results lend support to the hypothesis that antithrombotic and antiinflammatory medication (cyclooxygenase inhibitors) and nitrovasodilator treatments could interfere with the measurement of cerebrovascular reactivity resulting in underestimation of the cerebrovascular reserve capacity in patients taking these drugs.

AB - Since the nitric oxide (NO) and cyclooxygenase pathways have been suggested to have important roles in most vasodilations, our aim was to study the influence of cyclooxygenase inhibitors and nitrovasodilators on cerebrovascular reserve capacity. Corticocerebral blood flow was measured by hydrogen polarography during hypercapnia and acetazolamide stimuli in conscious rabbits. The measurements were repeated in the presence of Nω-nitro-L-arginine methyl ester (L-NAME) and indomethacin as nitric oxide synthase (NOS) and cyclooxygenase inhibitors. The effects of nitroglycerin and isosorbide-5-nitrate were also tested. L-NAME completely, while indomethacin markedly inhibited the hypercapnic corticocerebral blood flow response. Nitroglycerin and isosorbide-5-nitrate significantly attenuated hypercapnia elicited corticocerebral blood flow increase. The different treatments reduced only moderately the acetazolamide-induced corticocerebral blood flow response. These results lend support to the hypothesis that antithrombotic and antiinflammatory medication (cyclooxygenase inhibitors) and nitrovasodilator treatments could interfere with the measurement of cerebrovascular reactivity resulting in underestimation of the cerebrovascular reserve capacity in patients taking these drugs.

KW - Acetazolamide

KW - Carbon dioxide

KW - Cerebral vasoreactivity

KW - Cyclooxygenase inhibitor

KW - Nitrovasodilator

UR - http://www.scopus.com/inward/record.url?scp=0035793309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035793309&partnerID=8YFLogxK

U2 - 10.1016/S0014-2999(01)00725-7

DO - 10.1016/S0014-2999(01)00725-7

M3 - Article

VL - 412

SP - 301

EP - 309

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 3

ER -